share_log

Aridis Receives Agreement From The European Medicines Agency On The Clinical Study Design And A Single Confirmatory Phase 3 Study Of AR-301

Benzinga ·  07/18/2023 04:09

Aridis Receives Agreement From The European Medicines Agency On The Clinical Study Design And A Single Confirmatory Phase 3 Study Of AR-301

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment